Cequa (ciclosporin 900 microgram/mL) is indicated to increase tear production in patients with moderate to severe dry eye where prior use of artificial tears has not been sufficient.1,2 Cequa is available via private prescription and on the PBS for patients with chronic severe dry eye disease with keratitis.3
Contact: Sun Pharma (AUS) 1800 726 229
PBS Information: Authority Required. Refer to PBS schedule for full authority information.
Please review the Product Information before prescribing available from www.ebs.tga.gov.au.
This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information.
Healthcare professionals are asked to report any suspected adverse events at tga.gov.au/reporting-problems.
Date of preparation: July 2023 CEQ01/2023MIVI2
References
- Cequa Approved Product Information.
- Goldberg, D.F. et al. Ophthalmology 2019; 126:1230–7.
- Pharmaceutical Benefits Scheme (pbs.gov.au).
